Methods and uses for diagnosing and treating Tourette syndrome are encompassed, wherein diagnosis and treatment may be based upon an assessment of genetic alterations metabotropic glutamate receptor (mGluR) network genes and Wherein treatment with nonspecific activators of mGluRs such as fasoracetam.
